Just give it a good shake or stir before drinking
#biotech #pharma #drugdevelopment #FDA To view or add a comment, sign in For a decade, potent PCSK9 inhibition meant an injection and this week it became a pill
this article could not confirm the reason for that apparent mismatch
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
While response time varies, many patients notice improvements in gut health, recovery speed, or reduced inflammation within the first few weeks
For readers focused on how appetite changes can affect day-to-day nutrition, our tirzepatide weight-loss timeline article offers another perspective